🇸🇬 Caplyta in Singapore

Caplyta (LUMATEPERONE) regulatory status in Singapore.

Marketing authorisations

HSA

  • Status: likely_approved

HSA

  • Status: likely_approved

Caplyta in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Other Neuroscience approved in Singapore

Frequently asked questions

Is Caplyta approved in Singapore?

Yes. HSA has authorised it; HSA has authorised it.

Who is the marketing authorisation holder for Caplyta in Singapore?

Intra-Cellular is the originator. The local marketing authorisation holder may differ — check the official source linked above.